Professor Allison Cowin is a leading authority in wound healing and scar formation, recognized internationally for her contributions to regenerative medicine. Based at the University of South Australia, she has published over 200 peer-reviewed papers, editorials, and book chapters, advancing knowledge in cytoskeletal regulation of wound repair and stem cell therapies. Her cross-disciplinary scientific approach, combining fundamental cell biology with complex in vivo models, has driven significant new developments and clinical translation in the field.

Allison is co-leading a SAAFE supported project to develop new antimicrobial alternatives to reduce antibiotic use in livestock disease management. This collaboration between Calix and the University of South Australia focuses on screening nanostructured magnesium oxide and its derivatives for antimicrobial efficacy using 2D planktonic and 3D biofilm models. Lead compounds will be assessed for their potential to prevent and treat diseases such as skin infections, offering a promising alternative to traditional antibiotics.

Professor Cowin’s interest in AMR research stems from the growing concern of wound infections, which can lead to amputations and even death. The overuse of antibiotics and the rise of MRSA in hospitals highlight the urgent need for alternative treatment approaches. Through her work with SAAFE, she hopes to develop solutions that reduce antibiotic reliance and improve infection management for both humans and animals.